Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

SOE 2019 – David Keegan – Implantable miniature telescope   

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 14th 2019

David Keegan shares his experiences with the implantable miniature telescope for patients with AMD, and shares his tips on avoiding complications and helping patients with postoperative rehabilitation.

Questions:
1. Could you tell us a little about the implantable miniature telescope and how it is implanted?
2. Which AMD patients are most likely to benefit from an IMT?
3. In which patients is the IMT contraindicated?
4. What are the most common complications of IMT surgery and how may these be overcome?
5. What are the most important methods of postoperative rehabilitation for patients receiving an IMT?

Disclosures: David Keegan has received financial support from Vision Care.

Filmed in partnership with European Society of Ophthalmology (SOE).

touchOPHTHALMOLOGY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup